ResMed
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $1,431,406 | $1,422,808 | $1,335,582 | $1,347,993 |
Gross Profit | 890,979 | 884,660 | 820,820 | 820,070 |
EBITDA | 499,810 | 566,426 | 503,284 | 532,341 |
EBIT | 504,096 | 455,586 | 458,053 | |
Net Income | 398,732 | 392,593 | 348,536 | 379,705 |
Net Change In Cash | 1,431,406 | 1,422,808 | 1,335,582 | 1,347,993 |
Free Cash Flow | 520,478 | 311,206 | 414,356 | 508,181 |
Cash | 1,660,513 | 1,417,069 | 1,383,848 | 1,209,450 |
Basic Shares | 147,037 | 147,037 | 147,037 | 147,037 |
Annual Financials
| Values in thousands | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
Revenue | $5,146,327 | $4,685,297 | $4,222,993 | $3,578,127 |
Gross Profit | 3,054,970 | 2,655,303 | 2,355,662 | 2,024,311 |
EBITDA | 1,913,377 | 1,533,543 | 1,358,801 | 1,176,636 |
EBIT | 1,677,566 | 1,317,334 | 1,162,279 | 982,795 |
Net Income | 1,400,723 | 1,020,951 | 897,556 | 779,437 |
Net Change In Cash | 5,146,327 | 4,685,297 | 4,222,993 | 3,578,127 |
Free Cash Flow | 1,661,723 | 1,286,404 | 559,299 | 195,111 |
Cash | 1,209,450 | 238,361 | 227,891 | 273,710 |
Basic Shares | 147,340 | 147,550 | 147,455 | 147,043 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $2.86 |
2025-12-31 | $2.81 |
2025-09-30 | $2.37 |
2025-06-30 | $2.55 |